Latest & greatest articles for Lymphoid Hyperplasia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on Lymphoid Hyperplasia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on Lymphoid Hyperplasia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via

Top results for Lymphoid Hyperplasia

1. Nodular Lymphoid Hyperplasia. (Abstract)

Nodular Lymphoid Hyperplasia. 27468084 2016 08 09 2016 07 29 1533-4406 375 3 2016 Jul 21 The New England journal of medicine N. Engl. J. Med. IMAGES IN CLINICAL MEDICINE. Nodular Lymphoid Hyperplasia. e3 10.1056/NEJMicm1514403 Sharma Vishal V Postgraduate Institute of Medical Education and Research, Chandigarh, India Ahuja Arvind A Dr. Ram Manohar Lohia Hospital, New Delhi, India. eng Case Reports Journal Article United States N Engl J Med 0255562 0028-4793 AIM IM

2016 NEJM